Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Total Assets of $6.67 million for fiscal year 2025.
ADIAL PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.67M | +32.3% |
| 2024 | $5.04M | +6.5% |
| 2023 | $4.74M | -17.4% |
| 2022 | $5.73M | -23.3% |
| 2021 | $7.47M | +36.1% |
| 2020 | $5.49M | -28.5% |
| 2019 | $7.68M | +63.4% |
| 2018 | $4.70M | +13503.0% |
| 2017 | $34.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.66M | -15.7% | -16.8% |
| June 30, 2025 | $6.80M | +37.4% | +97.1% |
| March 31, 2025 | $3.45M | -48.4% | -31.6% |
| December 31, 2024 | $5.04M | +6.5% | -24.9% |
| September 30, 2024 | $6.71M | +134.1% | +35.6% |
| June 30, 2024 | $4.95M | +31.0% | -26.0% |
| March 31, 2024 | $6.68M | +71.3% | +41.1% |
| December 31, 2023 | $4.74M | -17.4% | +65.2% |
- ADIAL PHARMACEUTICALS, INC. showed an increase of +32.3% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, ADIAL PHARMACEUTICALS, INC.’s total assets has grown by 19217.3% (from $34.5 thousand to $6.67 million).
- The most recent figure is from ADIAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: